Allergy drops for dust mite rhinitis
Part of Immune system & allergy clinical trials.
This trial tests allergy drops placed under the tongue to treat allergic rhinitis caused by house dust mites. It aims to see if the drops can safely reduce symptoms like sneezing and stuffy nose.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 60 years old.
- You have had allergic rhinitis (runny nose, sneezing, itching) for at least 6 months.
- Your skin test for dust mites shows a wheal (bump) at least 5 mm wide.
- Your specific IgE blood test for dust mites is class 3 or higher.
- Your lung function test shows FEV1 is at least 70% of predicted normal.
- You have daily nose symptom scores of at least 6 for at least 5 days in a 10-day period before the trial starts.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a spray placed under the tongue to treat allergic rhinitis caused by dust mites, pet dander, or mold. It looks at how the spray affects the bacteria in your nose and body.
This study looks at how a dust-mite allergy tablet (placed under the tongue) affects the tiny organisms in your nose. It may help doctors understand why some people respond better to the treatment.
This study tests a new tablet (Lupatadine Fumarate) for people with nasal allergies caused by dust mites. It looks at how well the medicine works and what it does in the body.
This trial tests a dust-mite allergy extract (“allergy shots”) to see if it safely reduces symptoms from dust-mite–driven hay fever (rhinitis/rhinoconjunctivitis), and possibly asthma symptoms. If you qualify, it may help your immune system tolerate dust mites better over time.
This trial tests an under-the-tongue tablet for people with dust mite allergies causing moderate to severe nasal symptoms or mild-to-moderate asthma. The goal is to see if it improves symptoms and can replace or reduce the need for allergy medicines.
This trial tests if allergy shots (allergen-specific immunotherapy) can reduce symptoms of moderate to severe dust mite allergy. You will be in a room that exposes you to dust mites to see how well the treatment works, compared to a placebo.
Hear when a new Allergic Rhinitis Due to Dust Mite trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.